17. Patients with Grade 3 or 4 GVHD of the GI tract; patients with any GI disease that would, in the judgment of the investigator, preclude the patient from taking or absorbing oral medication (e.g. clinically active Crohn's disease, ischemic colitis, moderate or severe ulcerative colitis, or any condition expected to require abdominal surgery during the course of study participation).